Takayasu Arteritis (tak) Clinical Trials
2 recruiting trials for Takayasu Arteritis (tak). Eligibility criteria explained in plain English.
TrialFinderData lists 2 Takayasu Arteritis (tak) clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by University of Edinburgh (1), University of Pennsylvania (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Questionnaire (other, 1 trial), followed by Online questionnaires.
Track Takayasu Arteritis (tak) trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Investigating Management, Perspectives and Attitudes Towards Care in Takayasu Arteritis
This study aims to understand the experiences of patients with Takayasu arteritis (TAK) and how physicians manage the condition. To achieve this, two separate questionnaires will...
Vasculitis Pregnancy Registry
The purpose of this study is to learn about the experience of women with vasculitis who become pregnant. In particular, the study will consist of several online surveys to assess...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Takayasu Arteritis (tak), with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Takayasu Arteritis (tak), review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Takayasu Arteritis (tak), representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.